Submission of postal ballot results and scrutinizer report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company announced results of its postal ballot concluded on 7th December 2025, with all three special resolutions passed with overwhelming majority. Resolution 1 approved changing the company name from 'Remedium Lifecare Limited' to 'Supha Pharmachem Limited' with 97.96% votes in favour. Resolution 2 approved the appointment of Mr. Vignesh Laxman Gawde as Executive Director/Whole Time Director for 5 years, with 97.57% approval. Resolution 3 approved the appointment of Mr. Rambhajan Vishwakarma as Non-Executive Director and Chairman of the Board, with 97.66% approval. Voting was conducted via remote e-voting through NSDL, out of 115,265 total shareholders on record. Ms. Riddhi Shah, Practicing Company Secretary, acted as the scrutinizer for the process.
The name change reflects a rebranding likely tied to the company's pivot into the pharmachem space, which may help align its market identity with its core business. The appointment of a new Executive Director and Chairman signals a possible leadership refresh. All resolutions received very high shareholder support, suggesting no governance controversy.